Lionco Pharmaceutical Group Co.,Ltd. (603669.SS)
CNY 6.69
(-3.04%)
CNY 6.69
(-3.04%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 56.76 Million CNY | 15.53% |
| 2022 | 49.13 Million CNY | -4.89% |
| 2021 | 51.66 Million CNY | -25.19% |
| 2020 | 69.06 Million CNY | -23.1% |
| 2019 | 89.8 Million CNY | 29.59% |
| 2018 | 69.3 Million CNY | -24.29% |
| 2017 | 91.54 Million CNY | 13.84% |
| 2016 | 80.41 Million CNY | -7.32% |
| 2015 | 86.76 Million CNY | 9.83% |
| 2014 | 78.99 Million CNY | 5.1% |
| 2013 | 75.16 Million CNY | 8.89% |
| 2012 | 69.02 Million CNY | 6.75% |
| 2011 | 64.66 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 61.48 Million CNY | 63.84% |
| 2024 Q1 | 58.46 Million CNY | 2.99% |
| 2024 Q2 | 37.52 Million CNY | -35.82% |
| 2023 Q4 | 56.76 Million CNY | -17.13% |
| 2023 FY | 56.76 Million CNY | 15.53% |
| 2023 Q3 | 68.5 Million CNY | 39.67% |
| 2023 Q1 | 65.09 Million CNY | 32.47% |
| 2023 Q2 | 49.04 Million CNY | -24.65% |
| 2022 Q4 | 49.13 Million CNY | 8.26% |
| 2022 Q2 | 43.85 Million CNY | -9.71% |
| 2022 FY | 49.13 Million CNY | -4.89% |
| 2022 Q3 | 45.38 Million CNY | 3.5% |
| 2022 Q1 | 48.57 Million CNY | -5.99% |
| 2021 Q1 | 78.28 Million CNY | 13.34% |
| 2021 Q3 | 57.33 Million CNY | -24.13% |
| 2021 FY | 51.66 Million CNY | -25.19% |
| 2021 Q4 | 51.66 Million CNY | -9.89% |
| 2021 Q2 | 75.56 Million CNY | -3.46% |
| 2020 FY | 69.06 Million CNY | -23.1% |
| 2020 Q1 | 91.34 Million CNY | 1.71% |
| 2020 Q2 | 107.89 Million CNY | 18.12% |
| 2020 Q3 | 97.67 Million CNY | -9.47% |
| 2020 Q4 | 69.06 Million CNY | -29.29% |
| 2019 FY | 89.8 Million CNY | 29.59% |
| 2019 Q3 | 78.23 Million CNY | -5.78% |
| 2019 Q4 | 89.8 Million CNY | 14.79% |
| 2019 Q2 | 83.03 Million CNY | 3.58% |
| 2019 Q1 | 80.16 Million CNY | 15.67% |
| 2018 Q1 | 75.67 Million CNY | -17.33% |
| 2018 FY | 69.3 Million CNY | -24.29% |
| 2018 Q4 | 69.3 Million CNY | 7.11% |
| 2018 Q3 | 64.69 Million CNY | -6.18% |
| 2018 Q2 | 68.96 Million CNY | -8.87% |
| 2017 Q2 | 115.87 Million CNY | 19.79% |
| 2017 FY | 91.54 Million CNY | 13.84% |
| 2017 Q1 | 96.72 Million CNY | 20.29% |
| 2017 Q4 | 91.54 Million CNY | -24.81% |
| 2017 Q3 | 121.74 Million CNY | 5.06% |
| 2016 Q2 | 92.46 Million CNY | 1.78% |
| 2016 Q4 | 80.41 Million CNY | -18.23% |
| 2016 Q3 | 98.33 Million CNY | 6.35% |
| 2016 Q1 | 90.84 Million CNY | 4.7% |
| 2016 FY | 80.41 Million CNY | -7.32% |
| 2015 Q4 | 86.76 Million CNY | -7.38% |
| 2015 FY | 86.76 Million CNY | 9.83% |
| 2015 Q3 | 93.67 Million CNY | 8.07% |
| 2015 Q2 | 86.68 Million CNY | 0.0% |
| 2015 Q1 | - CNY | -100.0% |
| 2014 Q4 | 78.99 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | 78.99 Million CNY | 5.1% |
| 2013 FY | 75.16 Million CNY | 8.89% |
| 2012 FY | 69.02 Million CNY | 6.75% |
| 2011 FY | 64.66 Million CNY | 0.0% |